FDA approves Pfizer's treatment for rare blood cancer

The U.S. Food and Drug Administration said on Wednesday it approved Pfizer Inc's treatment for a rare form of blood cancer in some adults.

from Reuters: Health News https://ift.tt/2BoACxN
via IFTTT